Efficacy and safety of cadonilimab combined with chemotherapy for gastric or gastroesophageal junction adenocarcinoma: a single-arm meta-analysis

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-02-18
DOI
https://doi.org/10.3389/fimmu.2026.1693179
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of cadonilimab combined with chemotherapy for gastric or gastroesophageal junction adenocarcinoma: a single-arm meta-analysis

Xiangyang Yu, Jiaxin Li, Likun Yang, Zhengcun Pei et al.
Frontiers in Immunology
Cancer Immunotherapy and Biomarkers
article

Efficacy and safety of cadonilimab combined with chemotherapy for gastric or gastroesophageal junction adenocarcinoma: a single-arm meta-analysis

Xiangyang Yu, Jiaxin Li, Likun Yang, Zhengcun Pei, Ximo Wang
article en

Abstract

No abstract available for this paper.
Frontiers in ImmunologyVol. 17
Tianjin Medical University Cancer Institute and Hospital (CN), Tianjin Third Central Hospital (CN), Tianjin Medical University (CN)
National Natural Science Foundation of China
Good health and well-being
Openalex Percentile: Top 49%
Cancer Immunotherapy and Biomarkers
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.